Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiedu Quyu Zishen Fang is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of systemic lupus erythematosus (SLE). It is composed of multiple herbs and is designed to "clear toxins," "remove stasis," and "nourish the kidney" according to TCM theory. Clinical studies have shown that it can prevent and treat SLE, particularly in patients who are also receiving steroid therapy[1][3]. The mechanism of action involves modulation of immune responses, regulation of microRNAs related to inflammation and autoimmunity, as well as targeting molecular pathways such as STAT3, MAPK1, AKT1, HSP90AA1, and JUN[1][3]. The formula contains bioactive compounds like flavonoids (e.g., quercetin), iridoids, and phenolic acids that interact with key targets involved in inflammatory and fibrotic processes[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiedu Quyu Zishen Fang.